Bausch & Lomb (NYSE:BLCO) fell 5.6% in premarket trading ... and will not result in a transaction at this time." The eye care company said full separation remains the goal, according to the ...

Eye Drops for Red Eyes: LUMIFY significantly reduces redness to help reveal your eyes' natural radiance. From the eye care experts at Bausch and Lomb, LUMIFY works in 1 minute and lasts up to 8 ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global eye health company, has been navigating a complex market landscape characterized by both promising opportunities and significant challenges.

There are also eye drops that can help with dry eyes caused by wearing contact ... we highly recommend the Sensitive Eyes Contact Lens Solution by Bausch + Lomb for anyone with sensitive eyes ...

(RTTNews) - Bausch + Lomb Corporation (BLCO) is down by 8.45 percent during Thursday's trading, falling $1.56 to $16.19. The stock dropped after the company announced that its efforts to take the ...

Bausch & Lomb (NYSE:BLCO) fell 5.6% in premarket trading after ending a sales process without finding a buyer. “Taking Bausch + Lomb private with a third-party buyer was one of several options being ...

Bausch + Lomb's product portfolio, particularly its prescription Dry Eye Disease (DED) offerings, has been a focal point for investors and analysts. The company's newest DED drug, Miebo ...